Out For Tender › États-Unis › Services de recherche et développement et services de conseil connexes
Synthesis and Distribution of Drugs of Abuse and Related Compounds
- Acheteur
- NATIONAL INSTITUTES OF HEALTH NIDA, Health and Human Services, Department of
- Pays
- États-Unis
- Catégorie
- Services de recherche et développement et services de conseil connexes
- Date limite
- Clôture dans 14 jours (20 Nov 2026 13:00 UTC-5)
- Publié le
- 29 Oct 2026
- Procédure
- Sources Sought - Small Business Set Aside - Total
Lire l'avis officiel et soumissionner → La soumission se fait toujours sur le portail de l'acheteur, jamais ici.
Ce que l'acheteur demande
This is a SMALL BUSINESS SOURCES SOUGHT NOTICE. This is NOT a solicitation for proposals, proposal of abstracts or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses (e.g., 8(a), Veteran-owned small businesses, service-disabled Veteran-owned small businesses, HUBZone small businesses, small disadvantaged businesses, and women-owned small businesses); (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition; and (4) whether commercials sources and services are available in the marketplace. Your response to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code 541715 should not submit a response to this notice. This notice is issued to help determine the appropriate acquisition method including small business socioeconomic set aside possibilities and to determine the availability of commercial or non-commercial companies technically capable of meeting the Government's potential requirement. It is not construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. Furthermore, it should be noted that any future solicitations that may be issued as a result of this notice, or in response to this requirement, may be issued using a different solicitation number from the one identified above. The National Institute on Drug Abuse (NIDA) Division of Therapeutics and Medical Consequences (DTMC) and National Institutes of Health (NIH) is seeking Capability Statements from Small Business organizations with the demonstrated capability of providing service to support NIDA DTMC with the synthesis and distribution of drugs of abuse and related compounds. BACKGROUND AND OBJECTIVES: The National Institute on Drug Abuse (NIDA) is seeking capability statements from small businesses with the capability to synthesize and distribute drugs of abuse and related compounds. The NIDA Drug Supply Program has played an important role in promoting and supporting the substance use research by providing a wide variety of authentic, pure, controlled and uncontrolled drugs and other chemical compounds (both unlabeled and labeled with deuterium, tritium, carbon -14, and iodine-125 isotopes) to the drug abuse research community for basic research. To continue to supply authentic and pure drugs and research chemicals, NIDA maintains the drug supply inventory, periodically check chemical purity and supply to research investigators according to the NIDA drug supply guidelines. Specifically, NIDA plans to continue to: (1) produce, acquire, synthesize and maintain several radio and deuterium labeled and unlabeled drugs of abuse and other chemical substances in its drug supply inventory and distribute them to research investigators upon approval; (2) analyze, test, establish, and maintain the purity of drugs of abuse, and other chemical compounds in the NIDA drug supply inventory and produce updated chemical data sheets; (3) to replenish existing drug supply inventory with depleted drugs and research compounds with the synthesis or acquisition of depleted drug/chemical substances routinely; (4) to identify, acquire, and update the drug supply inventory with newly discovered chemical compounds useful for drug abuse research; (5) to use, maintain, and update the NIDA drug supply data base, known as Drug Inventory Supply Control System (DISCS); and (6) accept and process request…
Langue de cet avis : English. Le titre et la description sont affichés tels que publiés par l'acheteur.
How this compares
- This is one of 486 open tenders in États-Unis for Services de recherche et développement et services de conseil connexes.
- Bidders were given 22 days from publication to the deadline; the median for open tenders in États-Unis is 21 days.
More open tenders from this buyer
SMART IRB Governance, Administration, and Operations Support (GAOS)
NATIONAL INSTITUTES OF HEALTH NIDA, Health and Human Services, Department of
Synthesis and Distribution of Drugs of Abuse and Related Compounds
NATIONAL INSTITUTES OF HEALTH NIDA, Health and Human Services, Department of
Similar open tenders
Dispersive Mirror
SLAC Natl Accel Lab -DOE Contractor, Energy, Department of
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
DEFENSE HEALTH AGENCY, Dept of Defense
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
DEFENSE HEALTH AGENCY, Dept of Defense
Research, Development, Test & Evaluation (RDT&E) Support for the Center for Corrosion Science and Engineering (CCSE)
NAVAL RESEARCH LABORATORY, Dept of Defense
Research, Development, Test & Evaluation (RDT&E) Support for the Center for Corrosion Science and Engineering (CCSE)
NAVAL RESEARCH LABORATORY, Dept of Defense
Source: SAM · reference 75N98027R00006SB · JSON